Loading clinical trials...
Loading clinical trials...
A Multi-Center, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of BMS-986165 in Subjects With Moderate-to-Severe Plaque Psoriasis
Conditions
Interventions
BMS-986165
Placebo
+1 more
Locations
165
United States
Achieve Clinical Research
Birmingham, Alabama, United States
Coastal Clinical Research - Mobile
Mobile, Alabama, United States
Elite Clinical Studies
Phoenix, Arizona, United States
Arizona Research Center
Phoenix, Arizona, United States
Synexus - Tucson
Tucson, Arizona, United States
Hull Dermatology
Rogers, Arkansas, United States
Start Date
August 7, 2018
Primary Completion Date
September 2, 2020
Completion Date
September 2, 2020
Last Updated
January 30, 2023
NCT07474792
NCT06857942
NCT06979453
NCT07449234
NCT07471048
NCT07116967
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions